![RSV positivity associated with reduced serious bacterial infection risk [Classics Series]](https://www.2minutemedicine.com/wp-content/uploads/2013/09/800px-Respiratory_syncytial_virus_01-350x250.jpg)
Shionogi and UBE: Novel Antiviral Drug Demonstrates Efficacy in RSV Patients
RSV patients treated with antiviral drug S-337395 showed statistically significant reduction in viral load S-337395 is generally safe and well ...
Tag: RSV
Ziresovir reduces the severity of respiratory syncytial virus in hospitalized infants
1. Ziresovir, an antiviral drug targeted at respiratory syncytial virus (RSV), was superior to placebo in reducing signs and symptoms ...
#VisualAbstract: Ziresovir Reduces Signs and Symptoms in Hospitalized Infants with Respiratory Syncytial Virus Infection
Click here to read this study in NEJM. ©2024 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced ...
#VisualAbstract: Nirsevimab Reduces Hospitalization for RSV Bronchiolitis
Click here to read this study in NEJM. ©2024 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced ...
The 2 Minute Medicine Podcast Episode 39
Welcome to the 2 Minute Medicine Podcast, summarizing the latest medical studies, curated and written by practicing physicians. On this ...
Respiratory syncytial virus disproportionately affects pre-term infants over term infants
1. RSV-related ALRI incidence was significantly higher among preterm infants than term infants. 2. This pattern for RSV hospitalizations remained ...
RSV F protein vaccine reduces rates of maternal and infant RSV
1. In this randomized controlled trial, there was a decreased risk of any and severe respiratory syncytial virus (RSV) lower ...
#VisualAbstract: RSV Prefusion F Protein-Based Maternal Vaccine Lowers Risk of Infant RSV Infection but Increases the Risk of Preterm Birth
Click here to read this study in The New England Journal of Medicine. ©2024 2 Minute Medicine, Inc. All rights reserved. No ...
mRNA-based vaccine efficacious in preventing symptomatic RSV infection
1. In this randomized-controlled trial, an mRNA-based vaccine was efficacious at preventing symptomatic infection with respiratory syncytial virus (RSV) involving ...
#VisualAbstract: Nirsevimab prevents hospitalizations due to respiratory syncytial virus (RSV) in infants compared to standard care
Click here to read this study in NEJM. ©2023 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced ...